Liberal Think Tank Says How Biden, If President, Could Cut Drug Prices

By Ariel Cohen / September 17, 2020 at 6:00 AM
The Center for American Progress put together recommendations, intended for a Biden administration, that caution against waiting for Congress to lower drug prices and recommend immediately cutting what Medicare pays for drugs and lowering drug spending in the Affordable Care Act marketplaces. The authors, Maura Caslyn and Thomas Waldrop, say the next president should use march-in rights granted under the Bayh-Dole Act to license patents for coronavirus vaccines and drugs to generic drug makers. The Bayh-Dole Act lets federal...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.